Skip to
  1. Homepage
  2. Research and trials
  3. Research projects
Search by disease/gene

Search by disease/gene

*
(*) mandatory field


 

Other search option(s)

34 matching term(s)

Partnership : Academics = Academics, Industrials = Industrials, Financial investitors = Financial investitors

    • AUSTRIA
    • WIEN
    • WIEN
    • Therapeutic challenge in leukodystrophies
    • Medizinische Universität Wien
    • Pathobiology of the Nervous System
    • More details
    • AUSTRIA
    • WIEN
    • WIEN
    • MYELINET: Myelin orphan diseases in health (coordination)
    • Medizinische Universität Wien
    • Pathobiology of the Nervous System
    • More details
    • CANADA
    • Québec
    • MONTRÉAL
    • Clinical, radiological and genetic characterization of new forms of leukodystrophies
    • Montreal Children's Hospital Research Institute - McGill University
    • Pediatric Neurodegenerative Laboratory
    • More details
    • CANADA
    • Québec
    • MONTRÉAL
    • Clinical, molecular and pathophysiological characterization of POL III-related leukodystrophies
    • Montreal Children's Hospital Research Institute - McGill University
    • Pediatric Neurodegenerative Laboratory
    • More details
    • FRANCE
    • ALSACE
    • STRASBOURG
    • MYELINET: myeline repairing: role of steroids and sex in leukodystrophy
    • Université Louis Pasteur
    • Laboratoire d'Imagerie et de Neurosciences Cognitives
    • More details
    • FRANCE
    • ALSACE
    • STRASBOURG
    • MYELINET: myeline repairing: cellular and gene therapies strategies
    • Université Louis Pasteur
    • Laboratoire d'Imagerie et de Neurosciences Cognitives
    • More details
    • FRANCE
    • ALSACE
    • STRASBOURG
    • MYELINET: myeline repairing: animal models creation of myelin diseases
    • Université Louis Pasteur
    • Laboratoire d'Imagerie et de Neurosciences Cognitives
    • More details
    • FRANCE
    • ALSACE
    • STRASBOURG
    • MYELINET: myeline repairing: noninvasive white matter imaging
    • Université Louis Pasteur
    • Laboratoire d'Imagerie et de Neurosciences Cognitives
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • LE KREMLIN-BICÊTRE
    • MYELINET: myeline repairing: role of steroids and sex in leukodystrophy
    • GHU Paris-Sud - Hôpital de Bicêtre
    • Stéroïdes, neuroprotection et neurorégénération
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • LE KREMLIN-BICÊTRE
    • LEUKOTREAT: innovative gene and cell therapies in leukodystrophies (WP4)
    • GHU Paris-Sud - Hôpital de Bicêtre
    • Service de Neurologie Pédiatrique
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecules of guidance and remyelinisation in the central nervous system - study of leukodystrophy
    • CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
    • Biologie des interactions neurones / glie
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Role of Sox17 in the development and regeneration of oligodendrocytes from mouse and humain brain
    • CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
    • Equipe approche moléculaire et cellulaire de la remyélinisation
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Preclinical animal model development of the central nervous system demyelinisation, particularly in leukodystrophy
    • CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
    • Equipe approche moléculaire et cellulaire de la remyélinisation
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Function of repulsive proteins Slit and their receptors in proliferation, migration and differenciation of SVZ derivated neuronal precursors in normal and demyelinisated central nervous system, particularly in leukodystrophy
    • CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
    • Equipe approche moléculaire et cellulaire de la remyélinisation
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Role of the exogenous stem cells in the central nervous system remyelinisation
    • CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
    • Equipe approche moléculaire et cellulaire de la remyélinisation
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • LEUKOTREAT: innovative gene and cell therapies in leukodystrophies (WP4)
    • CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
    • Equipe approche moléculaire et cellulaire de la remyélinisation
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Function of repulsive proteins Slit and their receptors in proliferation, migration and differenciation of SVZ derivated neuronal precursors in normal and demyelinisated central nervous system, particularly in leukodystrophy
    • Centre de Recherche Institut de la Vision
    • Département Biologie du Développement
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • New mouse model to study the potential regeneration of glia, repairing of myelin and the interaction between oligodendrocytes / Schwann cells in leukodystrophy
    • ENS - Ecole Normale Supérieure de Paris
    • INSERM U784
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • LEUKOTREAT: ethical impacts of therapeutic challenges in leukodystrophies (WP5)
    • Faculté de Médecine des Saints Pères - Centre Universitaire des Saints-Pères
    • Laboratoire d'éthique médicale et médecine légale
    • More details
    • GERMANY
    • Hamburg
    • HAMBURG
    • LEUKOTREAT: characterizing leukodystrophies for therapies (WP1)
    • UKE - Universitätsklinikum Hamburg-Eppendorf
    • Arbeitsgruppe Degenerative Gehirnkrankheiten
    • More details
    • GERMANY
    • Niedersachsen
    • GÖTTINGEN
    • Role of the mitochondrial respiratory process in myelinisation and the interaction axons/glial cells
    • Max-Planck-Institut für experimentelle Medizin
    • Abteilung Neurogenetik
    • More details
    • GERMANY
    • Niedersachsen
    • GÖTTINGEN
    • LEUKOTREAT: pharmacological strategies to treat leukodystrophies (WP3)
    • Max-Planck-Institut für experimentelle Medizin
    • Abteilung Neurogenetik
    • More details
    • GERMANY
    • Niedersachsen
    • GÖTTINGEN
    • LEUKONET- Project 2: Characterization of cerebral alterations in children with unclassified and rare classified leukodystrophies using multiparametric magnetic resonance investigations
    • Universitätsmedizin Göttingen
    • Abteilung Pädiatrie II - Neuropädiatrie, Stoffwechsel und Endokrinologie
    • More details
    • GERMANY
    • Niedersachsen
    • GÖTTINGEN
    • Clinical and molecular characterization of genetically determined unclear white matter disorders
    • Universitätsmedizin Göttingen
    • Abteilung Pädiatrie II - Neuropädiatrie, Stoffwechsel und Endokrinologie
    • More details
    • GERMANY
    • Rheinland-Pfalz
    • MAINZ
    • Role of the secretion of oligodendroglial exosomes in glial cells for the signaling and the protection of neurons
    • Johannes Gutenberg-Universität Mainz
    • Abteilung Molekulare Zellbiologie
    • More details
    • GREECE
    • GREECE
    • HERAKLION
    • Role of the adhesion molecule TAG-1 in the function of glial cells
    • Institute of Molecular Biology and Biotechnology (IMBB)
    • Department of biology
    • More details
    • ITALY
    • LAZIO
    • ROMA
    • LEUKOTREAT: characterizing leukodystrophies for therapies (WP1)
    • IRCCS Ospedale Pediatrico Bambino Gesù
    • Unità di Malattie Neuromuscolari e Neurodegenerative, Laboratorio di Medicina Molecolare
    • More details
    • ITALY
    • LOMBARDIA
    • MILANO
    • LEUKOTREAT: innovative gene and cell therapies in leukodystrophies (WP4)
    • Istituto San Raffaele Telethon per la Terapia Genica - TIGET
    • Unità di Ricerca Clinica Pediatrica
    • More details
    • LEBANON
    • Beyrouth
    • BEIRUT
    • Identification et localisation du gène responsable d'une forme de leucodystrophie et d'oligodontie dans une grande famille
    • Université Saint-Joseph
    • Unité de génétique médicale
    • More details
    • SPAIN
    • Cataluña
    • L'HOSPITALET DE LLOBREGAT
    • LEUKOTREAT: biomarkers for leukodystrophies treatment (WP2)
    • IDIBELL - Instituto de Investigación Biomédica de Bellvitge
    • Laboratorio de Enfermedades Neurometabólicas
    • More details
    • UNITED KINGDOM
    • Cambridgeshire
    • CAMBRIDGE
    • Promoting the remyelinisation in aged central nervous system
    • Cambridge Veterinary School
    • Department of Veterinary Medicine
    • More details
    • UNITED KINGDOM
    • Cambridgeshire
    • CAMBRIDGE
    • NIHR BioResource - Rare Disease: SPEED - Specialist Pathology: Evaluating Exomes in Diagnostics
    • Wellcome Trust/MRC Building
    • Cambridge Institute for Medical Research
    • More details
    • UNITED KINGDOM
    • Lothian
    • EDINBURGH
    • Genetic disorders of human brain development
    • Western General Hospital
    • MRC Human Genetics Unit
    • More details
    • UNITED KINGDOM
    • West Midlands
    • BIRMINGHAM
    • NIPSIGEN - Clinical translation of non-invasive prenatal diagnosis (NIPD) for single gene disorders (Health Innovation Challenge Fund)
    • Birmingham Women's NHS Foundation Trust
    • Regional Genetics Unit
    • More details